These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1). Harter P; Hauke J; Heitz F; Reuss A; Kommoss S; Marmé F; Heimbach A; Prieske K; Richters L; Burges A; Neidhardt G; de Gregorio N; El-Balat A; Hilpert F; Meier W; Kimmig R; Kast K; Sehouli J; Baumann K; Jackisch C; Park-Simon TW; Hanker L; Kröber S; Pfisterer J; Gevensleben H; Schnelzer A; Dietrich D; Neunhöffer T; Krockenberger M; Brucker SY; Nürnberg P; Thiele H; Altmüller J; Lamla J; Elser G; du Bois A; Hahnen E; Schmutzler R PLoS One; 2017; 12(10):e0186043. PubMed ID: 29053726 [TBL] [Abstract][Full Text] [Related]
6. Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing. Llorin H; Graf M; Chun N; Ford J Cancer Genet; 2022 Nov; 268-269():22-27. PubMed ID: 36116289 [TBL] [Abstract][Full Text] [Related]
7. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis. Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771 [TBL] [Abstract][Full Text] [Related]
8. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444 [TBL] [Abstract][Full Text] [Related]
9. New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients. Gervas P; Klyuch B; Denisov E; Kiselev A; Molokov A; Pisareva L; Malinovskaya E; Choynzonov E; Cherdyntseva N Mol Biol Rep; 2019 Oct; 46(5):5537-5541. PubMed ID: 31273614 [TBL] [Abstract][Full Text] [Related]
10. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. Meric-Bernstam F; Brusco L; Daniels M; Wathoo C; Bailey AM; Strong L; Shaw K; Lu K; Qi Y; Zhao H; Lara-Guerra H; Litton J; Arun B; Eterovic AK; Aytac U; Routbort M; Subbiah V; Janku F; Davies MA; Kopetz S; Mendelsohn J; Mills GB; Chen K Ann Oncol; 2016 May; 27(5):795-800. PubMed ID: 26787237 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. Sukpan P; Kanokwiroon K; Sriplung H; Laochareonsuk W; Choochuen P; Auseng N; Wanawanakorn K; Sangkhathat S Asian Pac J Cancer Prev; 2023 Feb; 24(2):525-530. PubMed ID: 36853301 [TBL] [Abstract][Full Text] [Related]
12. High frequency of pathogenic non-founder germline mutations in Maksimenko J; Irmejs A; Trofimovičs G; Bērziņa D; Skuja E; Purkalne G; Miklaševičs E; Gardovskis J Hered Cancer Clin Pract; 2018; 16():12. PubMed ID: 29928469 [TBL] [Abstract][Full Text] [Related]
13. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019. Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870 [TBL] [Abstract][Full Text] [Related]
14. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. Silva FC; Lisboa BC; Figueiredo MC; Torrezan GT; Santos EM; Krepischi AC; Rossi BM; Achatz MI; Carraro DM BMC Med Genet; 2014 May; 15():55. PubMed ID: 24884479 [TBL] [Abstract][Full Text] [Related]
15. New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients. Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study. Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088 [TBL] [Abstract][Full Text] [Related]
17. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H; JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics. Bychkovsky BL; Lo MT; Yussuf A; Horton C; Richardson M; LaDuca H; Garber JE; Rana HQ Cancer; 2022 Mar; 128(6):1275-1283. PubMed ID: 34875721 [TBL] [Abstract][Full Text] [Related]
20. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. Tung N; Lin NU; Kidd J; Allen BA; Singh N; Wenstrup RJ; Hartman AR; Winer EP; Garber JE J Clin Oncol; 2016 May; 34(13):1460-8. PubMed ID: 26976419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]